Information  X 
Enter a valid email address

Company Name matching 'uniQure Inc'

Date
Time Source
Company
Announcement
30 Mar 2020 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Investor Conferences in April
26 Mar 2020 11:00 am GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Achievement of Target Patient Dosing in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Hemophilia B
03 Mar 2020 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences in March
02 Mar 2020 9:05 pm GNW Factsheet uniQure Inc. (0EE0) uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
  9:05 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
27 Feb 2020 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Presents Multiple New Preclinical Data on AMT-130 at the CHDI’s 15th Annual Huntington’s Disease Therapeutics Conference
04 Feb 2020 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Presentations at the Upcoming 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
31 Jan 2020 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences in February
19 Dec 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Publication of Preclinical Data for AMT-130 in Huntington’s Disease Supporting Non-Selective HTT-Lowering Approach
08 Dec 2019 9:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces One-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
02 Dec 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences in December
06 Nov 2019 2:16 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Clinical Data Presentations at the 61st American Society of Hematology (ASH) Annual Meeting
05 Nov 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces the Allowance of New Patent Providing Further Protection of the Padua and Padua-Related Variants of Factor IX in Gene Therapy
01 Nov 2019 11:00 am GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences in November
31 Oct 2019 11:00 am GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Publication of Positive Interim Data from Phase IIb Clinical Trial of Etranacogene Dezaparvovec
28 Oct 2019 11:00 am GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Third Quarter 2019 Results and Highlights Recent Company Progress
27 Sep 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences in October
06 Sep 2019 1:39 am GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Pricing of its Public Offering
04 Sep 2019 9:02 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Proposed Public Offering
03 Sep 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
30 Aug 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences in September
20 Aug 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Leadership Promotions and Executive Transition
29 Jul 2019 12:18 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Second Quarter 2019 Results and Highlights Recent Company Progress
26 Jul 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
06 Jul 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces 36 Weeks of Follow-Up Data from Phase IIb Study of AMT-061 and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
21 Jun 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Presentations at the Upcoming 27th Congress of the International Society on Thrombosis and Haemostasis (ISTH)
31 May 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
22 May 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Strengthens Intellectual Property Portfolio with Granted Patent Claims Covering AMT-130 for Huntington’s Disease
10 May 2019 1:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B
07 May 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Featured Presentations of New Data on Spinocerebellar Ataxia Type 3 at the 2019 American Academy of Neurology Annual Meeting
02 May 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces New Preclinical Data in Hemophilia A and Fabry Disease in Oral Presentations at the 22nd ASGCT Annual Meeting
01 May 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
29 Apr 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces First Quarter 2019 Results and Highlights Recent Company Progress
15 Apr 2019 5:15 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT)
08 Apr 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
29 Mar 2019 11:00 am GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
01 Mar 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
28 Feb 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces 2018 Financial Results and Highlights Recent Company Progress
27 Feb 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Presents New Preclinical Data on AMT-130 at the CHDI’s 14th Annual Huntington’s Disease Therapeutics Conference
15 Feb 2019 12:24 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Publications on AAV Gene Therapy Approach to Treating Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) in the Journal Molecular Therapy Nucleic Acids
08 Feb 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B
04 Feb 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of AMT-061 in Patients with Hemophilia B
30 Jan 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
22 Jan 2019 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease
03 Dec 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B
19 Nov 2018 5:15 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Highlights Pipeline Expansion and Advancements in Technology at Research & Development Day
15 Nov 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B
06 Nov 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Third Quarter 2018 Financial Results and Highlights Company Progress
05 Nov 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Host Research & Development Day on Monday, November 19 in New York City
31 Oct 2018 11:00 am GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
18 Oct 2018 11:55 am GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Development of a Highly Potent, Next-Generation Promoter for Liver-Directed Gene Therapies
17 Oct 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Presents New Data Demonstrating Its Large-Scale Manufacturing Capabilities at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting
16 Oct 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Presentations at the Upcoming Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)
28 Sep 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate in Multiple Upcoming Industry Conferences
24 Sep 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Provides Update on Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B
30 Aug 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure to Participate at Multiple Upcoming Conferences
23 Aug 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces First Patient Treated in Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B
08 Aug 2018 12:00 pm GNW Factsheet uniQure Inc. (0EE0) uniQure Announces Second Quarter 2018 Financial Results and Highlights Company Progress


Company Announcements Archive »

 
Headlines
Top categories

07-Apr-2020 04:50 PM

Broker Forecast - Jefferies International issues a broker note on John Wood Group PLC

Jefferies International today reaffirms its hold investment rating on John Wood Group PLC (LON:WG.) and cut its price target to 200p (from 350p). Sto ...

Company finder
Forthcoming announcements

a d v e r t i s e m e n t